Español
|
English
BUSCADOR
CIBER
INTRANET
LINKS
BULLETIN BOARD
WEBMAIL
Toggle navigation
MENÚ
Who we are
Scientific Director’s Welcome
Mission and objectives
Sctructure
Steering Committee Members
External Scientific Advisory Committee (ESAC) Members
Governing Board
Permanent Commission
Consortium Institutions
Head Office
Thematic Areas
Information Resources
Contact
Groups
Research Groups
Geographical Distribution
Research Programmes
Gastrointestinal Tumours
Breast and Gynecological Cancers
Respiratory Tract Tumours
Haematological Tumours
Precision Diagnostics and Therapies
Cancer molecular mechanisms
Experimental Models WM
Transversal Programme
Training and Mobility Programme
Work Modules
Liquid Biopsy WM
Experimental Models WM
Immuno Oncology WM
Platforms
Fatbank
Technology Offer
Press
Events
Boletines CIBER
CIBERONC Newsletter
Platforms
Technology Offer
Technology Offer
USE OF AN MNK kinase inhibitor for the treatment of Triple-negative breast cancer
New Predictive method for the progression of colorectal cancer
Biomarkers to predict the response to treatment of patients with metastatic melanoma
Method to predict the response of cancer to treatment with anti-PDI immunotherapy
New Strategy to Discriminate PRO-TUMORIGENIC Pathways.
Non-Invasive Methology for the Detection and Characterization of Breast Cancer Screening
Fatbank
Technology Offer
